Maitri Porecha - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Maitri Porecha's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today

Maitri Porecha

Verified

Correspondent, DNA India

Mumbai

Beats

Primary beats

Health India

Secondary beats

Service Wellness Arts Tattoo Culture Customer Experience Ecotravel Personal Development Public Health Initiatives Lifestyle Small Businesses Organic Content IVF

Final Covers

freelancing,health parenting, psychology wellness, motherhood mental health, relationships

Journalist Type

Seniority Positions

Industries

Media Production

Medium Formats

Content

Total articles 262

Covid-19: Biocon to amend phase-4 trial protocol for psoriasis drug Itolizumab
By Maitri Porecha Verified · The Hindu Business Line
Aug. 03, 2020
Drug controller instructs Serum Institute to revise protocol for Oxford Covid-19 vaccine clinical trial
By Maitri Porecha Verified · The Hindu Business Line
Jul. 29, 2020

As seen in

The Hindu Business Line,Dna India

Company Info

DNA India

+91 22398 88888

Founded: 2005